OrbiMed Capital GP V LLC
CIK 1615374 · last filed 2025-10-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.49B
Companies
8
Total Filings
21
Lifetime Open-Market Net
-$56.11M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PMVP | Director | 4,975,291 | $1.11 | $5.52M | $62.31M | 4 | 2025-10-27 |
| CRVS | Director | 8,341,338 | $11.93 | $99.51M | -$9.04M | 3 | 2025-07-01 |
| Tricida, Inc. (TCDA) Delisted | Director | 9,246,526 | $0.11 | $998.6K | $11.79M | 2 | 2022-11-25 |
| CMPX | Director | 14,510,319 | $2.03 | $29.46M | $591.8K | 1 | 2022-05-10 |
| INSP | Director | 158,500 | $42.70 | $6.77M | -$191.94M | 5 | 2020-08-14 |
| ARMO BioSciences, Inc. (ARMO) Delisted | 10%+ Owner | 3,709,356 | — | — | $0 | 1 | 2018-06-22 |
| RYTM | 10%+ Owner | 2,751,679 | $88.38 | $243.19M | $16.91M | 2 | 2018-05-24 |
| ASND | Director | 5,091,010 | $218.06 | $1.11B | $53.27M | 2 | 2018-05-16 |
Recent Filings · Page 2 of 3
21 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-06-23 | — | Buy (P) | +2,910,264 | $14.55M | |
| 2020-03-10 | INSP | Sell (S) | −1,000,000 | -$83.52M | EDGAR |
| 2019-11-29 | INSP | Sell (S) | −248,000 | -$17.53M | EDGAR |
| 2019-04-05 | Tricida, Inc. (TCDA) Delisted | Buy (P) | +450,000 | $16.20M | EDGAR |
| 2018-12-13 | INSP | Sell (S) | −1,229,544 | -$46.23M | EDGAR |
| 2018-06-22 | ARMO BioSciences, Inc. (ARMO) Delisted | U | −12,356,709 | -$617.84M | EDGAR |
| 2018-05-24 | RYTM | Sell (S) | −39,160 | -$1.19M | EDGAR |
| 2018-05-16 | ASND | Sell (S) | −20,600 | -$278.1K | EDGAR |
| 2017-10-10 | RYTM | Mixed | +8,703,885 | $18.11M | EDGAR |
| 2016-06-16 | CRVS | Buy (P) | +60,000 | $741.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.